Yan Wang1, Jialong Li1, Shuai Chang1, Yingxian Dong1, Guowei Che2. 1. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China. 2. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: cheguowei_hx@aliyun.com.
Abstract
PURPOSE: To compare the risk of developing lung cancer between breast cancer patients and the general population and explore the risk factors for the development of primary lung cancer after treatment for breast cancer. METHODS: The PubMed, EMBASE and Web of Science databases were searched from the establishment date to October 11, 2020. Two separate meta-analyses were performed: one focused on studies reporting the risk of subsequent lung cancer after breast cancer and one focused on studies exploring the risk factors for subsequent lung cancer in breast cancer patients. The standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) were combined to compare the risk of developing lung cancer between breast cancer patients and the general population. The relative risks (RRs) or odds ratios (ORs) with 95% CIs were combined to assess the association of clinicopathological parameters with the risk of developing lung cancer after breast cancer. All statistical analyses were conducted by STATA 12.0. RESULTS: A total of 15 studies involving 1,161,979 patients were eventually included in the first meta-analysis, and the pooled results indicated that female patients with breast cancer showed a significantly higher risk of developing subsequent lung cancer (SIR=1.25, P＜0.001). In addition, a total of 22 articles involving 3,090,620 patients were included in the second meta-analysis. The pooled results indicated that smoking (OR=9.73, P＜0.001) and radiotherapy (RR=1.40, P＜0.001) were risk factors for developing subsequent lung cancer in breast cancer patients, and chemotherapy (RR=0.69, P=0.002), positive estrogen receptor (ER) status (RR=0.93, P=0.014) and positive progesterone receptor (PR) status (RR=0.86, P＜0.001) were protective factors. Meanwhile, subgroup analysis based on the relative position of the breast and lung cancers (ipsilateral vs contralateral) was conducted, which indicated that radiotherapy only increased the risk of ipsilateral lung cancer in breast cancer patients (RR=1.27, P=0.001). CONCLUSIONS: Breast cancer patients are more likely to develop lung cancer than the general population, and the risk of developing primary lung cancer after breast cancer is affected by smoking, radiotherapy, chemotherapy, ER status and PR status.
PURPOSE: To compare the risk of developing lung cancer between breast cancerpatients and the general population and explore the risk factors for the development of primary lung cancer after treatment for breast cancer. METHODS: The PubMed, EMBASE and Web of Science databases were searched from the establishment date to October 11, 2020. Two separate meta-analyses were performed: one focused on studies reporting the risk of subsequent lung cancer after breast cancer and one focused on studies exploring the risk factors for subsequent lung cancer in breast cancerpatients. The standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) were combined to compare the risk of developing lung cancer between breast cancerpatients and the general population. The relative risks (RRs) or odds ratios (ORs) with 95% CIs were combined to assess the association of clinicopathological parameters with the risk of developing lung cancer after breast cancer. All statistical analyses were conducted by STATA 12.0. RESULTS: A total of 15 studies involving 1,161,979 patients were eventually included in the first meta-analysis, and the pooled results indicated that female patients with breast cancer showed a significantly higher risk of developing subsequent lung cancer (SIR=1.25, P＜0.001). In addition, a total of 22 articles involving 3,090,620 patients were included in the second meta-analysis. The pooled results indicated that smoking (OR=9.73, P＜0.001) and radiotherapy (RR=1.40, P＜0.001) were risk factors for developing subsequent lung cancer in breast cancerpatients, and chemotherapy (RR=0.69, P=0.002), positive estrogen receptor (ER) status (RR=0.93, P=0.014) and positive progesterone receptor (PR) status (RR=0.86, P＜0.001) were protective factors. Meanwhile, subgroup analysis based on the relative position of the breast and lung cancers (ipsilateral vs contralateral) was conducted, which indicated that radiotherapy only increased the risk of ipsilateral lung cancer in breast cancerpatients (RR=1.27, P=0.001). CONCLUSIONS:Breast cancerpatients are more likely to develop lung cancer than the general population, and the risk of developing primary lung cancer after breast cancer is affected by smoking, radiotherapy, chemotherapy, ER status and PR status.
Authors: Haiyan Zeng; Danyang Zheng; Willem J A Witlox; Antonin Levy; Alberto Traverso; Feng-Ming Spring Kong; Ruud Houben; Dirk K M De Ruysscher; Lizza E L Hendriks Journal: Front Oncol Date: 2022-06-10 Impact factor: 5.738